Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rabics is a Japanese contract research organization (CRO) that provides specialized drug discovery research services to the pharmaceutical and biotechnology industries. Headquartered in the Shonan Health Innovation Park in Fujisawa, Japan, the company focuses on the breeding, management, and supply of laboratory animals, including genetically modified and disease model animals. Originally established as a subsidiary of Takeda Pharmaceutical (Takeda Rabics), it was acquired by Hamri in 2017 and now operates as an independent service provider. Rabics offers a range of support services, including veterinary care, experimental assistance, and GLP-compliant facility management, maintaining AAALAC International accreditation for its animal care programs. The company plays a critical role in the Japanese drug discovery ecosystem by supporting researchers with high-quality animal models and technical expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rabics.